Bionano Genomics, Inc. (BNGO) Q2 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day, and welcome to the BioNano Second Quarter 2026 Earnings Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Webb Campbell from Gilmartin Group. Please go ahead. Thank you, operator, and good afternoon, everyone. Welcome to the BioNano Second Quarter 2026 Financial Results Conference Call. On the call today are Dr. Al Luterer, Chairman and Interim CEO of BioNano, and Mark Adamchak, BioNano's Vice President of Accounting and Principal Accounting Officer. After market closed today, BioNano issued a press release announcing its financial results for the second quarter of 2026. A copy of the release can be found on the Investor Relations page of the company's website. Certain statements made during this conference call may be forward-looking statements. Actual results may differ materially from such statements due to several factors and risks, some of which are identified in BioNano's press release and BioNano's report filed with the SEC. These forward-looking statements are based upon information available to BioNano today, August 10, 2026, and the company assumes no obligation to update statements as circumstances change. During our call, we may reference certain non-GAAP financial measures, which we believe provide useful information for investors. Reconciliations of these measures to GAAP can be found on our press release and slide deck. An audio recording and webcast replay of today's conference call will also be available online on the investor relations page of the company website. With that, I will turn the call over to Al. Well, thank you, Webb, and good afternoon, everyone. I'm pleased to be here with you all today to share our second quarter 2026 results. BioNano had a strong second quarter,...